Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › MS › Carthage › NPI 1255424016
Clinic

Vibha Vig MD PA

Vibha Vig MD PA was paid $3.93M by Medicaid between Jan 2018 and Dec 2024, across 71 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 42% of everything it billed.

33Billing provider infoVIBHA VIG MD PA
CARTHAGE, MS 39051
33aNPI1255424016assigned 10/02/2006
28Total paid$3.93M
24GClaims180,499
24DCodes billed71
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Primary Care Clinic/Center providers in Mississippi

Rank by total paid#4 of 85
Median peer was paid$100K
This provider vs. median39×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$50K$100K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201840,665$728K
201937,494$678K
202027,862$624K
202132,023$759K
202223,647$576K
20238,625$261K
2024incomplete10,183$304K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 42% 32,112 26,302 $1.67M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 9.6% 4,923 4,436 $377K
90460 Immunization administration through 18 years of age via any route, first or only component 7.0% 9,863 8,977 $274K
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 6.6% 3,585 3,105 $259K
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 5.3% 2,844 2,610 $208K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 3.7% 4,604 4,278 $147K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 3.7% 1,739 1,570 $146K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 3.7% 12,095 5,391 $146K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 3.3% 10,801 9,530 $129K
D0145 Oral evaluation for a patient under three years of age 2.8% 4,946 4,445 $109K
D1206 Topical application of fluoride varnish 2.1% 4,899 4,416 $84K
92551 1.4% 8,012 7,144 $57K
59 more codes
92567 1.0% 4,071 $41K
96110 Developmental screening, with scoring and documentation, per standardized instrument <1% 5,080 $33K
87807 <1% 2,652 $27K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 2,198 $27K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,052 $23K
S9470 Nutritional counseling, dietitian visit <1% 5,425 $23K
99401 <1% 1,665 $21K
99202 Office or other outpatient visit for the evaluation and management of a new patient, straightforward <1% 451 $19K
94664 <1% 2,667 $18K
99381 <1% 200 $15K
99214 Doctor's office visit, returning patient (more involved) <1% 187 $13K
90461 <1% 2,570 $11K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 303 $9K
96127 <1% 3,055 $8K
99173 <1% 8,072 $7K
96160 <1% 4,642 $5K
85018 <1% 3,148 $4K
0071A <1% 98 $3K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 427 $2K
81000 <1% 1,018 $2K
0072A <1% 75 $2K
36415 Collection of venous blood by venipuncture <1% 1,076 $2K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 1,985 $2K
94760 <1% 7,766 $1K
T1023 Screening to determine the appropriateness of consideration of an individual for participation in a specified program, project or treatment protocol, per encounter <1% 104 $1K
0001A <1% 54 $1K
0002A <1% 30 $997.12
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 13 $910.00
81025 <1% 131 $756.07
90651 <1% 578 $619.92
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 17 $510.09
90658 <1% 1,300 $243.66
81002 <1% 36 $76.34
90686 <1% 945 $50.03
96161 <1% 38 $46.39
90670 <1% 3,028 $0.48
90648 <1% 51 $0.18
90647 <1% 1,474 $0.04
90716 <1% 82 $0.02
90715 <1% 102 $0.01
90723 0% 1,710 $0.00
90680 0% 1,300 $0.00
91307 0% 184 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 0% 4,373 $0.00
3008F 0% 99 $0.00
90698 0% 80 $0.00
90697 0% 373 $0.00
90677 0% 311 $0.00
90620 0% 18 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 0% 117 $0.00
90696 0% 65 $0.00
90633 0% 1,271 $0.00
90734 0% 364 $0.00
99408 0% 563 $0.00
90681 0% 105 $0.00
90700 0% 69 $0.00
91300 0% 78 $0.00
90707 0% 67 $0.00
90710 0% 63 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialVIG, VIBHA (OWNER)
Same official

Other billing entities under VIG, VIBHA

Full network →
ProviderLocationPaid
Vibha Vig MD PACanton, MS$6.28M
Vibha Vig MD PAYazoo City, MS$4.51M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.